Memorial Sloan Kettering Cancer Center: Lung Neoplasms trials

The registry lists 94 Lung Neoplasms studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 7 are open to participants now and 24 have results posted.

Early Phase 1 1Phase 1 29Phase 2 40Phase 3 3No phase 31(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Lung Cancer RiskRecruitingNCT07701733
• A Study of a Side Effects and Resource Navigation Program for People With CancerRecruitingNCT07646847Not applicable
• A Registry for People With Lung CancerRecruitingNCT06424327
• A Study of Mental Health Care in People With CancerRecruitingNCT06037954Not applicable
• Empathic Communication Skills (ECS) TrainingRecruitingNCT05456841Not applicable
• A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the BrainRecruitingNCT05419076Phase 2
• Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With SurgeryRecruitingNCT04991025Phase 2
• Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung CancerCompletedNCT03704688Phase 1/2Results posted
• Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant MesotheliomaCompletedNCT03399552Phase 1/2Results posted
• A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to ErlotinibCompletedNCT03076164Phase 1/2Results posted
• Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung CancersCompletedNCT02803203Phase 1/2Results posted
• Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung CancersCompletedNCT02525653Phase 2Results posted
• Irreversible Electroporation Ablation for Colorectal Metastases to the LungCompletedNCT02461550Not applicableResults posted
• Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung MetastasesCompletedNCT02181829Phase 2Results posted
• Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) PatientsCompletedNCT02016872Not applicableResults posted
• Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12DCompletedNCT01833143Phase 2Results posted
• Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)CompletedNCT01443078Phase 2Results posted
• Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or GefitinibTerminatedNCT01189435Phase 2Results posted
• Lung Cancer Exercise Training StudyCompletedNCT01068210Not applicableResults posted
• Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Epidermal Growth Factor Receptor (EGFR) Activating MutationsTerminatedNCT00988169Phase 2Results posted
• Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response AssessmentCompletedNCT00807573Phase 2Results posted
• Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung CancerCompletedNCT00740636Phase 2Results posted
• Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung CancerCompletedNCT00675597Not applicableResults posted
• Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung CancerCompletedNCT00590902Phase 2Results posted
• Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor GeneCompletedNCT00588445Phase 2Results posted
• Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON)CompletedNCT00577707Phase 2Results posted
• Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or GefitinibCompletedNCT00570401Phase 2Results posted
• Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerCompletedNCT00445965Phase 2Results posted
• Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or MesotheliomaCompletedNCT00398138Phase 1Results posted
• Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLCCompletedNCT00130780Phase 2Results posted
• Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung CancerCompletedNCT00096486Phase 1/2Results posted
• A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung CancerCompletedNCT06863233Phase 1
• A Study Comparing Mindfulness Apps to Decrease Anxiety in People With Lung CancerActive, not recruitingNCT06008574Not applicable
• Using e-Nose Technology to Identify Early Lung CancerActive, not recruitingNCT04734145
• Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation TherapyActive, not recruitingNCT04716946Phase 2
• Safety of Lung Cryobiopsy in People With CancerCompletedNCT04548830Phase 2
• Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung CancerActive, not recruitingNCT03999710Phase 2
• Continued Access to RXDX-105CompletedNCT03784378Phase 1
• A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.CompletedNCT03755102Early Phase 1
• A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint InhibitorsActive, not recruitingNCT03693014Phase 2
• RO5126766 for Patients With Advanced KRAS-Mutant Lung CancerCompletedNCT03681483Phase 1
• A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung CancersActive, not recruitingNCT03567642Phase 1
• A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung CancerCompletedNCT03532880Phase 1
• Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.Active, not recruitingNCT03220477Phase 1
• Clinician-Patient Communication in Lung Cancer CareActive, not recruitingNCT02732834
• Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant CancersCompletedNCT02675829Phase 2
• Respiratory Motion-Corrected Cone-Beam CT and Intratreatment Gating Based on Electromagnetic Transponders to Reduce Target Position Uncertainty in Radiation Treatment of Lung MalignanciesActive, not recruitingNCT02434809Not applicable
• Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen MesothelinActive, not recruitingNCT02414269Phase 1/2
• Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung CancerCompletedNCT01967095Phase 1
• Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung CancerCompletedNCT01899989Phase 1
• Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive ChemoradiationWithdrawnNCT01836341Phase 1
• Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung CancersCompletedNCT01579994Phase 1
• Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)CompletedNCT01579929Phase 1
• Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance ImagingTerminatedNCT01473693
• Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer PatientsCompletedNCT01466946
• Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic AcidCompletedNCT01349647Phase 1
• Molecular Determinants of Acquired Clinical Resistance to Crizotinib in Non-small Cell Lung Cancer Harboring a Translocation or Inversion Event Involving the ALK Gene LocusCompletedNCT01300429
• Breathing Synchronized PET/CT Scans for the Detection of Malignant Lung & Liver Lesions and Assessment of Tumor GlycolysisTerminatedNCT01052766Not applicable
• Support Needs and Preferences of Family Caregivers of Lung Cancer PatientsCompletedNCT00967083
• Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked CigarettesCompletedNCT00745160
• Physical Activity Intervention for Lung Cancer SurvivorsCompletedNCT00717795
• DNA Repair and Genetic Susceptibility to Lung CancerCompletedNCT00611598
• Prevalence+Significance of Paraneoplastic Autoantibodies in Many CancersCompletedNCT00608452
• Genetic Susceptibility to Lung Cancer in Never SmokersActive, not recruitingNCT00597636
• Quality of Life in Lung Cancer SurvivorsCompletedNCT00586937
• Physical Activity and Inactivity in Lung Cancer SurvivorsCompletedNCT00582348
• Assess the Variability of Uni-Dimensional, Bi-Dimensional, and Volumetric CT Scan Measurement of Non-Small Cell Lung Cancer TumorsCompletedNCT00579852
• Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung CancerCompletedNCT00579683
• Germline Alterations of Tumor Susceptibility Genes in New York Cancer PatientsActive, not recruitingNCT00579514Not applicable
• Methylated Genes in Blood as Biomarkers for Advanced Lung CancerCompletedNCT00579462
• Lung Cancer Informational Study (LCIS)CompletedNCT00579215Not applicable
• Depression Screening in Patients With Lung CancerCompletedNCT00404365Not applicable
• Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung CancerCompletedNCT00260026Phase 2
• Acupuncture for Post-Thoracotomy PainCompletedNCT00142532Phase 3
• Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based ChemotherapyCompletedNCT00081107Phase 2
• ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung CancerCompletedNCT00077246Phase 1/2
• Alanosine in Treating Patients With CancerCompletedNCT00062283Phase 2
• Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate CancerCompletedNCT00059943Phase 2
• Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00045604Phase 1
• TLK286 in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00036920Phase 2
• INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung CancerCompletedNCT00008255Phase 2
• Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate CancerCompletedNCT00006019Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00005806Phase 1
• Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by SurgeryCompletedNCT00005636Phase 3
• Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung CancerCompletedNCT00005630Phase 1
• Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung MetastasesCompletedNCT00004930Phase 1
• Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial TherapyCompletedNCT00004249Phase 2
• 10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00004238Phase 2
• Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerCompletedNCT00004065Phase 1
• Chemotherapy in Treating Patients With Solid TumorsCompletedNCT00003103Phase 1/2
• Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung CancerCompletedNCT00003037Phase 1/2
• Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerCompletedNCT00003022Phase 1
• PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by SurgeryCompletedNCT00002930Phase 2/3
• Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung CancerCompletedNCT00002484Phase 1